Coordination of mental health care in the USA is constrained by lack of portable and mutually sync’d record between a patient’s providers
Create a “min. patient file” (MPF) as a verifiable credential (VC) in PRISM. Patients share MPF with providers, who update & issue it back.
This is the total amount allocated to R&D for mental health credentials.
Background and Context
91M US adults with a behavioral health disorder in 2019 (NAMI) and 45% (41M) of whom are receiving treatment. A typical mental healthcare patient will have more than one provider – a psychiatrist, psychologist, primary care physician etc – but coordinating between those providers usually falls to the patient and can be time-consuming and error-prone. Our team accepts the opinion of 600+ peer-reviewed articles that better care coordination results in better mental health care. Our goal over the last several months has been to learn where in the broad spectrum of mental health care the need for care coordination is most acute. This acute area of need will be our starting point for developing a product which solves a known problem for a narrowly defined customer that is representative of a large market opportunity.
Our team has already done 100+ customer discovery interviews with patients, care providers, thought leaders, think tanks, NGOs and investors. We have discovered two acute areas of need where we believe we could enter the market:
This proposal focuses on the latter, university mental health, as we have an opportunity to collaborate with the student wellness team at a major US university with more than 30k students. We also learned through our interviews that parents are a highly motivated stakeholder in the dynamic of student mental health care coordination, and so possibly the payer in our business model. The opportunity is to run a focus group with a group of 100+ parents and students for whom, off the back of the focus group, we would be able to pilot a solution.
Simultaneously, we would engage with several care providers to understand what might be their specific needs as it relates to receiving and/or sharing health information with parents/students and other care providers for care coordination purposes. In particular, we would need to understand how a new product would need to fit in with their existing ways of working in order to be adopted.
This opportunity represents the fruit of over a year of research conversations, networking and building relationships among university mental healthcare professionals. There is a limited window as our university partner intends to run a program for parents of university students with mental health diagnoses and we have been invited to run our workshop during the program. In our experience opportunities like this to study the challenge of coordinating mental healthcare with input from students, parents and the university at one table are incredibly rare and we would like to ensure we can participate.
Our objective is to:
Our audience is:
The outputs will be:
The impact will be:
The proposal brings adoption of Atala PRISM credentials on Cardano to a major potential use case (market value >$1.5bn) with deliverables the achieve the following two criteria:
The proposal will align with the success goals of the challenge:
Patchy problem definition: a focus group and survey may reveal that the problem is not succinctly defined across given stakeholder group. This heterogeneity presents a marketing challenge and execution challenge. The way to mitigate is by addressing a core set of requirements as early as possible, in the ideation exercise.
Problems too great to be solved: these issues are systemic by nature so we expect the problems to be complex. Navigating the complexity to find the narrowest possible solution is at once challenging, and the main purpose of this proposal.
Care providers don’t want to use a new system: we have heard over and over that providing a new system to care providers that changes their current way of working is a huge barrier. We seek to minimise/eliminate that barrier by (a) making sure that other stakeholders do the data entry and rely on care providers for a limited / semi-automated set of functions (b) provide integration points with their existing infrastructure so that they do not have change systems.
April/May
June
July
Our total budget for this propels is $19,936 and we provide an activity-based budget below. Our budget follows the following format:
Activity cost
BUDGET
4 x focus groups, each costing - $ 1,974.00
1 x prototype design - $ 2,680.00
20 x care provider interviews, each costing - $ 368.00
4 x internal travel, each costing - $500
TOTAL = $19,936
Prof. André Fenton, PhD: NYU Professor of Neural Science, Director of the Neurobiology of Cognition Laboratory, Med Tech Entrepreneur and Public Intellectual, Advisor to US National Institute of Mental Health Leadership.
Sasha Borovik: Negotiated the first cloud deals under HIPAA and GDPR, and General Counsel for VC deals worth $500m. Microsoft Head Legal Counsel for Healthcare, Management of Akamai, Advisor to WHO.
Nick Mason: Delivered independently evaluated & ID2020 certified MedTech for CLIA labs. Decentralised ID lead (ProofSpace) & 10yrs social impact venture building in Europe and Africa.
John Gridley: Built & exited digital platforms for millions of users in regulated markets. PwC & 20 years’ in Tier 1 VC tech and medtech, clinical trials and FDA 510 (k) approval of neurological medical devices. 2021 exit to Philips as angel investor in AI health co. Currently a volunteer mentor and angel investor in femtech and social impact startups, member of new social impact angel investment group.
Progression of this proposal will be recorded in the monthly Catalyst reports and an end of project report, evaluated against the project deliverables (see below).
May
June
July
Success in this proposal would look like:
No
SDG Goals
SDG Subgoals
We are an NYU spin-off. Collectively our team has >50 years experience: Developing and commercializing patented medical devices, Managing WW healthcare at Microsoft, Conducting NIH-funded clinical trials, Winning FDA 510 (k) device approval, sales to healthcare systems globally.